11 Amendments of Ska KELLER related to 2011/0401(COD)
Amendment 33 #
Proposal for a regulation
Recital 20
Recital 20
(20) With the aim of deepening the relationship between science and society and reinforcing public confidence in science, Horizon 2020 should favourHorizon 2020 should: promote active participation and informed engagement of citizens and civil society oin the process of research and innovation matters by promoting science education, by making scientific knowledge more accessible, by developing; promote science education; guarantee the respect of ethical legislation and promoting the emergence of, and adherence to, the highest ethical standards worldwide; increase the accessibility and re-use of the results of publicly funded research, in particular scientific publications and data; develop responsible research and innovation and governance framework agendas that meet citizens' and civil society's concerns and expectations and by facilitatreinforcing their participation in the setting of research priorities of Horizon 2020 activities.
Amendment 35 #
Proposal for a regulation
Recital 24
Recital 24
(24) Research and innovation activities supported by Horizon 2020 should respect fundamental ethical principles. The opinions of the European Group on Ethics in Science and New Technologies should be taken into account. Research activities should also take into account Article 13 TFEU and reduce the use of animals in research and testing, with a view ultimately to replacing animal use. All activities should be carried out ensuring a high level of human health protection in accordance with Article 168 TFEU. Ethical principles, such as the Helsinki Declaration, require that scientific data produced or collected by publicly funded research conducted on humans are made public, irrespective of where they take place in Europe or elsewhere in the world.
Amendment 44 #
Proposal for a regulation
Article 16 – paragraph 1 – subparagraph 1 a (new)
Article 16 – paragraph 1 – subparagraph 1 a (new)
Ethical principles, including the Helsinki Declaration, require that scientific data produced or collected by publicly funded research conducted on humans, for instance in the context of clinical trials, are made public and accessible.
Amendment 57 #
Proposal for a regulation
Article 21 – paragraph 2 – subparagraph 1
Article 21 – paragraph 2 – subparagraph 1
Targeted actions with the objective of promoting cooperation with specific third countries or groups of third countries shall be implemented on the basis of common interest and mutual benefit, taking into account their scientific and technological capabilities and market opportunities, and the expected impact. They include actions dedicated to the reinforcement of research capacities in developing countries and cooperation actions centred on their specific needs in domains such as health, including research on neglected diseases and epidemics, agriculture, fisheries and environment.
Amendment 59 #
Proposal for a regulation
Article 22 – paragraph 1
Article 22 – paragraph 1
The European Commission shall implement information and communication actions concerning Horizon 2020, including communication measures concerning supported projects and results. In order to increase the circulation and exploitation of knowledge and maximize the efficiency of research efforts, free open online access to scientific publications, already embraced in the Seventh Framework Programme, shall be the general principle for scientific publications of research receiving public funding from Horizon 2020. Free open access to scientific data produced or collected through research funded by Horizon 2020 shall be promoted and tested with the objective of making it mandatory in 2020. Budget allocated to communication under Horizon 2020 shall also contribute to covering the corporate communication of the Union's political priorities as far as they are related to the general objective of this Regulation.
Amendment 63 #
Proposal for a regulation
Annex I – paragraph 15
Annex I – paragraph 15
All the activities shall take a challenge- based approach, focusing on policy priorities without predetermining the precise choice of technologies or solutions that should be developed. The emphasis shall be on bringing together a critical mass of resources and knowledge across different fields, technologies and scientific disciplines in order to address the challenges. The activities shall cover the full cycle from research to market, with a new focus on innovation-related activities, such as piloting, demonstration, test-beds, support for public procurement, design, end-user driven innovation, the use of innovative research funding tools such as innovation awards – particularly in cases where the market fails to fulfil its proper function and where Europe and the rest of the world are confronted with major challenges – social innovation and market take-up of innovations.
Amendment 67 #
Proposal for a regulation
Annex I – part I – point 3.3 – point c – paragraph 2
Annex I – part I – point 3.3 – point c – paragraph 2
Key activities shall be to support short- term exchanges of research and innovation staff among a partnership of universities, research institutions, businesses, SMEs and other socio-economic groups, both within Europe and worldwide. This will include fostering cooperation with third countries, and, in particular, strengthening scientific partnerships between the Union and developing countries.
Amendment 71 #
Proposal for a regulation
Annex I – part III – point 1.1 – paragraph 4
Annex I – part III – point 1.1 – paragraph 4
Chronic conditions such as cardiovascular disease (CVD), cancer, diabetes, neurological and mental health disorders, overweight and obesity and various functional limitations are major causes of disability, ill-health and premature death, and present considerable social and economic costs. Innovative models for funding and disseminating the results of research work, such as innovation awards, are of essential importance in addressing these societal challenges and enabling researchers in Europe and the rest of the world to play an active and effective part in doing so.
Amendment 76 #
Proposal for a regulation
Annex I – part III – point 1.2 – paragraph 1
Annex I – part III – point 1.2 – paragraph 1
Disease and disability are not stopped by national borders. An appropriate European -level research and innovation response in partnership with third countries can and should make a crucial contribution to addressing these global challenges, thus helping to a achieve the Millennium Development Goals and to deliver better health and well-being for all, and to position Europe as a leader in the rapidly expanding global markets for health and well-being innovations.
Amendment 77 #
Proposal for a regulation
Annex I – part III – point 1.2 – paragraph 2
Annex I – part III – point 1.2 – paragraph 2
The response depends on excellence in research to improve our fundamental understanding of health, disease, disability, development and ageing (including of life expectancy), and on the seamless and widespread translation of the resulting and existing knowledge into innovative, scalable and, effective and accessible products, strategies, interventions and services. Furthermore, the pertinence of these challenges across Europe and in many cases, globally, demands a response characterised by long term and coordinated support for co- operation between excellent, multidisciplinary and multi-sector teams.
Amendment 81 #
Proposal for a regulation
Annex I – part III – point 1.3 – paragraph 5
Annex I – part III – point 1.3 – paragraph 5
Specific activities shall include: understanding the determinants of health (including environmental and climate related factors), improving health promotion and disease prevention; understanding disease and improving diagnosis; developing effective screening programmes and improving the assessment of disease susceptibility; improving surveillance and preparedness; developing better preventive vaccines; using in-silico medicine for improving disease management and prediction; treating disease; transferring knowledge to clinical practice and scalable innovation actions; better use of health data; active ageing, independent and assisted living; individual empowerment for self-management of health; promotion of integrated care; improving scientific tools and methods to support policy making and regulatory needs; and optimising the efficiency and effectiveness of healthcare systems and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches, in particular in relation to funding research and disseminating research results in order to share knowledge that will facilitate and speed up innovation in these areas.